US Stocks
/
Cingulate Inc. Share Price
Cingulate Inc. Share Price

Cingulate Inc. Share Price

NASDAQ: CING | Micro Cap
$5.20
+$0.11 (2.16%) Last updated on 19 Sep, 2026 | 01:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Cingulate Inc. Stock Performance

Open
$5.16
Prev. Close
$5.09
Circuit Range
N/A
Day Range
$5.16 - $5.25
Year Range
$3.19 - $11.78
Volume
1,796
Average Traded
$5.22

Cingulate Inc. Share Price Today

As of 19 September 2026, Cingulate Inc.'s share price is $5.20. The stock opened at $5.16, compared to its previous close of $5.09. During today's trading session, Cingulate Inc.'s share price traded between $5.16 and $5.25, with an average price of $5.20. Over the past 52 weeks, the stock has recorded a high of $11.78 and a low of $3.19. In terms of performance, Cingulate Inc.'s share price has declined by 15.52% over the last six months and is up 32.65% on a year-on-year basis.

Cingulate Inc. Share Price Chart

$5.16$5.25
L
Show Current Price
H

Cingulate Inc. Stock Fundamentals & Key Indicators

Market Cap
$26.29M
PE Ratio (TTM)
-1.17
Dividend Yield
N/A
EPS (TTM)
$-4.44
Revenue (TTM)
N/A
Return On Equity (TTM)
-894.81%
Profit Margin
N/A
Debt to Equity
4.11
Quarterly Earnings Growth YoY
-127.16%

Cingulate Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$2.97M-$3.21M-$3.23M-$3.80M-$4.79M-$7.34M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A-7.98%-0.68%-17.67%-25.93%-53.30%

Cingulate Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
RevenueN/AN/AN/AN/AN/A
Net Profit-$20.71M-$17.68M-$23.53M-$15.55M-$22.45M
Net Profit MarginN/AN/AN/AN/AN/A
Income ChangeN/A14.65%-33.14%33.95%-44.41%

About Cingulate Inc.

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company develops medications capable of once-daily dosing using its proprietary drug delivery platform technology, Precision Timed Release. Its drug candidates include CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials, as well as CTx-1302 (dextroamphetamine), which is in Phase 1/2 clinical pharmacology and Phase 3 clinical efficacy and safety trials for the treatment of ADHD in children, adolescents, and adults; and CTx-2103 (buspirone) that is in a formulation stage for the treatment of anxiety and related disorders. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.

Cingulate Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$5.16
$5.20
-3.53%
Aug 2026
$4.87
$5.39
+12.76%
Jul 2026
$5.63
$4.78
-12.29%
Jun 2026
$3.29
$5.45
+32.12%
May 2026
$5.16
$4.13
-19.35%
Apr 2026
$6.38
$5.12
-16.90%
Mar 2026
$6.01
$6.16
-1.83%
Feb 2026
$5.87
$6.27
+9.62%
Jan 2026
$4.31
$5.72
+32.71%
Dec 2025
$3.65
$4.31
+16.02%
Nov 2025
$3.69
$3.71
-1.59%
Oct 2025
$3.96
$3.77
-3.70%

CING Share Price FAQs

What is Cingulate Inc. share price today?

chevron-up
Cingulate Inc. share price today is $5.20 as on September 19, 2026 at 1:27 am IST.

What is the 52 week high and 52 week low of Cingulate Inc. stock?

chevron-up
The 52 week high of Cingulate Inc. stock is $11.78, while the 52 week low is $3.19 as of 19 Sep '26.

What is CING's market capitalisation today?

chevron-up
CING market capitalisation is $26.29M as of September 19, 2026, at 11:43 am IST.

What is CING's net income for the last quarter?

chevron-up
CING's net income for the last quarter is -0.01B USD.

What is the 5 year returns of CING?

chevron-up
The 5 year returns of CING is -99.21% as on 19 Sep '26.

What is the high & low stock price of CING today?

chevron-up
CING stock price hit a high of $5.25 and low of $5.16 as of 19 Sep '26.

Can I buy CING shares in India?

chevron-up
Yes. You can buy CING in India by opening an international trading account.